Top Markets
Coin of the day
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Classement en actions #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Prix de l'action
$1.83
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$6.53M
Changement (1 jour)
-1.61%
Changement (1 an)
-85.57%
Pays
US
Échange Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Catégorie

Le prix CVKD avec la capitalisation boursière de B
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
CVKD
$1.83
Capitalisation boursière de Cadrenal Therapeutics, Inc. Common Stock(CVKD)
Capitalisation boursière: $6.53M
En August 2026, Cadrenal Therapeutics, Inc. Common Stock a une capitalisation boursière de $6.53M. Cela fait de Cadrenal Therapeutics, Inc. Common Stock la 33958th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Cadrenal Therapeutics, Inc. Common Stock du 2023 au 2026
CVKD par rapport au top 5 des plus populaires stocks
Prix pour CVKD L’actif B La capitalisation boursière de B Résultats
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,528,108 $6.53M
$5.452T +83,503,043.85%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,258,511 $6.53M
$4.490T +68,770,974.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,166,684 $6.53M
$4.162T +63,753,110.65%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,030,444 $6.53M
$3.676T +56,308,337.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$794,075 $6.53M
$2.833T +43,391,995.61%